Keywords: intrinsa, gets, fda, priority, review, food, drug

P&G's Intrinsa gets FDA priority review

Article | 27 September 2004

Print This

The US Food and Drug Administration has granted priority review to Procter & Gamble's Intrinsa, a testosterone skin patch for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in